Natixis’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1
Closed -$18 1098
2024
Q3
$18 Buy
+1
New +$18 ﹤0.01% 927
2024
Q2
Sell
-1
Closed -$35 1047
2024
Q1
$35 Hold
1
﹤0.01% 965
2023
Q4
$44 Hold
1
﹤0.01% 991
2023
Q3
$38 Hold
1
﹤0.01% 943
2023
Q2
$41 Hold
1
﹤0.01% 982
2023
Q1
$57 Buy
+1
New +$57 ﹤0.01% 950
2022
Q3
Sell
-23,487
Closed -$1.27M 1013
2022
Q2
$1.27M Buy
+23,487
New +$1.27M ﹤0.01% 729
2022
Q1
Sell
-9,000
Closed -$603K 1236
2021
Q4
$603K Buy
9,000
+958
+12% +$64.2K ﹤0.01% 1000
2021
Q3
$551K Sell
8,042
-4,570
-36% -$313K ﹤0.01% 995
2021
Q2
$861K Buy
12,612
+5,612
+80% +$383K ﹤0.01% 633
2021
Q1
$484K Hold
7,000
﹤0.01% 944
2020
Q4
$454K Buy
+7,000
New +$454K ﹤0.01% 910
2020
Q2
Sell
-43,099
Closed -$1.93M 795
2020
Q1
$1.93M Buy
+43,099
New +$1.93M 0.02% 392
2019
Q4
Sell
-58,940
Closed -$3.54M 891
2019
Q3
$3.54M Buy
58,940
+14,373
+32% +$864K 0.02% 406
2019
Q2
$2.49M Sell
44,567
-94,790
-68% -$5.29M 0.02% 418
2019
Q1
$7.72M Sell
139,357
-16,449
-11% -$912K 0.05% 312
2018
Q4
$7.03M Buy
155,806
+40,446
+35% +$1.82M 0.06% 273
2018
Q3
$7.6M Buy
115,360
+3,598
+3% +$237K 0.04% 320
2018
Q2
$7.2M Buy
111,762
+32,837
+42% +$2.12M 0.04% 333
2018
Q1
$4.37M Buy
+78,925
New +$4.37M 0.03% 381
2017
Q4
Sell
-80,412
Closed -$4.06M 992
2017
Q3
$4.06M Buy
80,412
+24,468
+44% +$1.24M 0.04% 296
2017
Q2
$3.05M Buy
55,944
+5,938
+12% +$324K 0.03% 287
2017
Q1
$2.11M Buy
50,006
+43,338
+650% +$1.83M 0.03% 304
2016
Q4
$286K Buy
+6,668
New +$286K ﹤0.01% 655